JP2003342171A - ディスラノール投与のための組成物 - Google Patents

ディスラノール投与のための組成物

Info

Publication number
JP2003342171A
JP2003342171A JP2003144983A JP2003144983A JP2003342171A JP 2003342171 A JP2003342171 A JP 2003342171A JP 2003144983 A JP2003144983 A JP 2003144983A JP 2003144983 A JP2003144983 A JP 2003144983A JP 2003342171 A JP2003342171 A JP 2003342171A
Authority
JP
Japan
Prior art keywords
composition
phase
weight
lipid
vesicles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003144983A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003342171A5 (https=
Inventor
Suresh Kumar Gidwani
クマー ギドワニ サレシュ
Purushottam Sharshikant Singnurkar
シャーシカント シングナーカー パルショッタム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
USV Pvt Ltd
Original Assignee
USV Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by USV Pvt Ltd filed Critical USV Pvt Ltd
Publication of JP2003342171A publication Critical patent/JP2003342171A/ja
Publication of JP2003342171A5 publication Critical patent/JP2003342171A5/ja
Pending legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/21—Emulsions characterized by droplet sizes below 1 micron
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Nanotechnology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2003144983A 2002-05-23 2003-05-22 ディスラノール投与のための組成物 Pending JP2003342171A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38299702P 2002-05-23 2002-05-23
US60/382997 2002-05-23
US10/371,295 US20030219465A1 (en) 2002-05-23 2003-02-21 Composition for delivery of dithranol
US10/371295 2003-02-21

Publications (2)

Publication Number Publication Date
JP2003342171A true JP2003342171A (ja) 2003-12-03
JP2003342171A5 JP2003342171A5 (https=) 2006-07-06

Family

ID=29406719

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003144983A Pending JP2003342171A (ja) 2002-05-23 2003-05-22 ディスラノール投与のための組成物

Country Status (8)

Country Link
US (1) US20030219465A1 (https=)
EP (1) EP1364642B1 (https=)
JP (1) JP2003342171A (https=)
AT (1) ATE335466T1 (https=)
DE (1) DE60307358T2 (https=)
DK (1) DK1364642T3 (https=)
ES (1) ES2269920T3 (https=)
PT (1) PT1364642E (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014507273A (ja) * 2011-02-03 2014-03-27 シュテアグ エナジー サーヴィシィズ ゲゼルシャフト ミット ベシュレンクテル ハフツング 蓄積した鉄化合物を持つｓｃｒ触媒を処理するための方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004274000B2 (en) * 2003-09-19 2009-07-30 Drugtech Corporation Pharmaceutical delivery system
RU2385711C2 (ru) * 2005-03-21 2010-04-10 Лайфкэр Инновейшнз Пвт. Лтд. Многослойная везикулярная композиция
CN101374501A (zh) * 2006-01-05 2009-02-25 药物技术公司 组合物及其使用方法
ATE554743T1 (de) * 2007-09-19 2012-05-15 Bubbles & Beyond Gmbh Reinigungsmittel zur entfernung von farbschichten von oberflächen, verfahren zur herstellung des mittels und verfahren zur reinigung
US9789123B2 (en) 2010-10-21 2017-10-17 Cadila Healthcare Limited Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis
MX2013004296A (es) * 2010-10-21 2013-09-26 Cadila Healthcare Ltd Composiciones farmaceuticas topicas que contienen gotas de tamaño nanometrico para el tratamiento de soriasis.
CN103860387B (zh) * 2014-03-06 2016-01-20 东南大学 水杨酸纳米结构脂质载体及其制备方法和应用
US11191704B2 (en) 2014-08-20 2021-12-07 Amantin Experts Compositions and methods for controlled moisturizing and release of active ingredients

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62185012A (ja) * 1986-02-07 1987-08-13 レ−ム・フアルマ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 皮膚疾患の局所治療用適用剤
JPH04503676A (ja) * 1989-10-27 1992-07-02 シェーリング　アクチェンゲゼルシャフト 医薬品
JPH05503071A (ja) * 1989-08-18 1993-05-27 ジョン・モリス・カンパニー・インク ケラチン組織、皮膚状態を治療し、創傷の治癒を促進させる臭気遮断及び安定化組成物
JPH06183953A (ja) * 1991-06-24 1994-07-05 Nippon Oil & Fats Co Ltd 混合脂質膜小胞
US5358716A (en) * 1991-09-17 1994-10-25 L'oreal Pharmaceutical composition for topical application containing dithranol and preparation process
JPH07309754A (ja) * 1994-02-16 1995-11-28 Roussel Uclaf リポソームよりなる化粧用又は医薬用組成物
JPH09501161A (ja) * 1993-07-03 1997-02-04 ザ、プロクター、エンド、ギャンブル、カンパニー パーソナルクレンジング組成物
JPH10265383A (ja) * 1997-03-25 1998-10-06 Takaaki Akaike 医薬組成物
JPH11505262A (ja) * 1995-05-22 1999-05-18 シエーリング アクチエンゲゼルシヤフト 脱毛治療及び脱毛予防のための局所適用可能な薬剤
JPH11509545A (ja) * 1995-07-20 1999-08-24 ダンバイオシスト、ユーケー、リミテッド ビタミンｅを含む脂質ビヒクル薬剤送達組成物
WO2000028972A2 (de) * 1998-11-17 2000-05-25 Novosom Gmbh Nanokapseln und verfahren zur herstellung dieser
WO2000042990A1 (en) * 1999-01-25 2000-07-27 Optime Therapeutics, Inc. Liposome formulations
JP2000229815A (ja) * 1999-02-05 2000-08-22 Toshimitsu Hattori リポソームおよびその利用
WO2000057918A2 (en) * 1999-03-31 2000-10-05 Abbott Laboratories Novel formulations comprising lipid-regulating agents
WO2000072823A1 (en) * 1999-05-27 2000-12-07 Euroceltique S.A. Preparations for the application of anti-inflammatory agents
WO2001068081A1 (de) * 2000-03-13 2001-09-20 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819657A (en) * 1972-10-20 1974-06-25 Gen Mills Chem Inc Methylation of tocopherols
US4102995A (en) * 1976-05-13 1978-07-25 Westwood Pharmaceuticals Inc. Tar gel formulation
US4287214A (en) * 1979-09-24 1981-09-01 Scott Eugene J Van Dithranol compositions stabilized with alpha hydroxyacids
US4367224A (en) * 1981-05-13 1983-01-04 Scott Eugene J Van Stable dithranol compositions in anhydrous vehicles
US4551480A (en) * 1983-06-21 1985-11-05 Stiefel Laboratories, Inc. Compositions for the treatment of psoriasis
US4911928A (en) * 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US5260065A (en) * 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
US5439967A (en) * 1991-09-17 1995-08-08 Micro Vesicular Systems, Inc. Propylene glycol stearate vesicles
US5476664A (en) * 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
US6068847A (en) * 1996-10-03 2000-05-30 Johnson & Johnson Consumer Products, Inc. Cosmetic compositions
FR2755856B1 (fr) * 1996-11-21 1999-01-29 Merck Clevenot Laboratoires Microcapsules de chitine ou de derives de chitine contenant une substance hydrophobe, notamment un filtre solaire et procede de preparation de telles microcapsules
ATE372377T1 (de) * 1998-03-30 2007-09-15 Mibelle Ag Cosmetics Verwendung von nanoemulsionen zur bestimmung der biokompatibilität von lipophilen stoffen im zellkultur-test und dafür geeignete nanoemulsionen

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62185012A (ja) * 1986-02-07 1987-08-13 レ−ム・フアルマ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 皮膚疾患の局所治療用適用剤
JPH05503071A (ja) * 1989-08-18 1993-05-27 ジョン・モリス・カンパニー・インク ケラチン組織、皮膚状態を治療し、創傷の治癒を促進させる臭気遮断及び安定化組成物
JPH04503676A (ja) * 1989-10-27 1992-07-02 シェーリング　アクチェンゲゼルシャフト 医薬品
JPH06183953A (ja) * 1991-06-24 1994-07-05 Nippon Oil & Fats Co Ltd 混合脂質膜小胞
US5358716A (en) * 1991-09-17 1994-10-25 L'oreal Pharmaceutical composition for topical application containing dithranol and preparation process
JPH09501161A (ja) * 1993-07-03 1997-02-04 ザ、プロクター、エンド、ギャンブル、カンパニー パーソナルクレンジング組成物
JPH07309754A (ja) * 1994-02-16 1995-11-28 Roussel Uclaf リポソームよりなる化粧用又は医薬用組成物
JPH11505262A (ja) * 1995-05-22 1999-05-18 シエーリング アクチエンゲゼルシヤフト 脱毛治療及び脱毛予防のための局所適用可能な薬剤
JPH11509545A (ja) * 1995-07-20 1999-08-24 ダンバイオシスト、ユーケー、リミテッド ビタミンｅを含む脂質ビヒクル薬剤送達組成物
JPH10265383A (ja) * 1997-03-25 1998-10-06 Takaaki Akaike 医薬組成物
WO2000028972A2 (de) * 1998-11-17 2000-05-25 Novosom Gmbh Nanokapseln und verfahren zur herstellung dieser
WO2000042990A1 (en) * 1999-01-25 2000-07-27 Optime Therapeutics, Inc. Liposome formulations
JP2000229815A (ja) * 1999-02-05 2000-08-22 Toshimitsu Hattori リポソームおよびその利用
WO2000057918A2 (en) * 1999-03-31 2000-10-05 Abbott Laboratories Novel formulations comprising lipid-regulating agents
WO2000072823A1 (en) * 1999-05-27 2000-12-07 Euroceltique S.A. Preparations for the application of anti-inflammatory agents
WO2001068081A1 (de) * 2000-03-13 2001-09-20 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014507273A (ja) * 2011-02-03 2014-03-27 シュテアグ エナジー サーヴィシィズ ゲゼルシャフト ミット ベシュレンクテル ハフツング 蓄積した鉄化合物を持つｓｃｒ触媒を処理するための方法

Also Published As

Publication number Publication date
PT1364642E (pt) 2006-11-30
DE60307358D1 (de) 2006-09-21
DE60307358T2 (de) 2007-08-16
EP1364642B1 (en) 2006-08-09
EP1364642A1 (en) 2003-11-26
ES2269920T3 (es) 2007-04-01
ATE335466T1 (de) 2006-09-15
US20030219465A1 (en) 2003-11-27
DK1364642T3 (da) 2006-11-27

Similar Documents

Publication Publication Date Title
JP4173533B2 (ja) 超微小油球体を用いての局部用及び経皮用投与システム
US11541006B2 (en) Aqueous formulation for insoluble drugs
TWI290052B (en) Emulsion vehicle for poorly soluble drugs
DE69809074T2 (de) Herstellung von arzneimitteln
AU2010335654B2 (en) Cutaneous composition comprising vitamin D analogue and a mixture of solvent and surfactants
EP3840730A1 (en) Compositions for the delivery of therapeutic agents and methods of use and making thereof
EP3280398B1 (en) Self-emulsifying formulations of dim-related indoles
JP2006008700A (ja) 超微小油球体を用いての局部用及び経皮用投与システム
JP2003513019A (ja) トコール可溶性治療剤の組成物
JPH11509545A (ja) ビタミンｅを含む脂質ビヒクル薬剤送達組成物
NZ500769A (en) Activated dihydroxy- and hydroxyvitamin D3 emulsion-type lotions for treating psoriasis
AU2003220643B2 (en) Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
JP2003342171A (ja) ディスラノール投与のための組成物
JP2023525160A (ja) 毛包内への生物活性剤の送達のための組成物
JP6322575B2 (ja) 脂質マイクロカプセルのデリバリービヒクルを含む局所用製剤およびその使用
JP7740933B2 (ja) 化粧料用リポソーム含有組成物、及び化粧料
JPS63319046A (ja) 被覆脂肪乳剤
US20100221350A1 (en) Dermatological compositions comprising vitamin d lipid vesicles
KR20230025582A (ko) 병풀 정량 추출물의 나노 현탁 조성물 및 이의 제조 방법

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060518

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060518

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100126

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100629